PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism (NCT05756244)
A Prospective Cohort Study Evaluating Peripartum Anticoagulation Management Among Pregnant Women With Venous Thromboembolism and Its Impact on Patient Outcomes
🩺 Plain-English Summary (8th-Grade Level)
The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (7 items) and avoid the listed exclusions (4 items).
Location: Duke University Hospital — Durham, North Carolina
Age range: 18 Years to 60 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Anticoagulation for a non-VTE indication, including prosthetic heart valves, atrial fibrillation, prevention of placenta-mediated pregnancy complications, or prevention of recurrent pregnancy loss (participants can be included with a diagnosis of antiphospholipid syndrome (APS) with or without thrombotic events)
- Unable to provide or declined consent.
- Home or birthing centre planned delivery.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (14 Sites)
- Duke University Hospital — Durham, North Carolina
- Foothills Medical Centre — Calgary, Alberta
- Royal Alexandra Hospital — Edmonton, Alberta
- BC Women's Hospital and Health Centre — Vancouver, British Columbia
- St. Boniface Hospital — Winnipeg, Manitoba
- McMaster University Medical Centre — Hamilton, Ontario
- The Ottawa Hospital - General Campus — Ottawa, Ontario
- Montfort Hospital — Ottawa, Ontario
- Mount Sinai Hospital — Toronto, Ontario
- CHU Sainte-Justine — Montreal, Quebec
- The Sir Mortimer B. Davis Jewish General Hospital — Montreal, Quebec
- Aarhus University Hospital — Aarhus,
- Le Centre Hospitalier Universitaire of Saint-Etienne — Saint-Etienne,
- Hopitaux universitaires de Geneve — Geneva,
📞 Contact the Study Coordinator
Phone: (403) 220-7103
Email: jbaxter@ucalgary.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pregnancy Related
- Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE — Milwaukee, Wisconsin
- Trial of Community-based Patient Navigation — Atlanta, Georgia
- Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population — Morrisville, North Carolina
- Impact of Lactation Antenatal Teaching by Clinicians and Healthcare Providers — Loma Linda, California
- Natural Versus Programmed Frozen Embryo Transfer (NatPro) — San Francisco, California
Explore by condition: All Pregnancy Related clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.